Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

134.52 -0.67 (-0.49%)
Streaming Delayed Price Updated: 2:14 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
52 53 Next >
News headline image
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test ↗
Though successful in early testing, it wasn't enough to win a Phase 3 study. 
Via Investor's Business Daily
News headline image
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings ↗
 
Via Benzinga
News headline image
Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More.. ↗
Reuters 
Via Benzinga
News headline image
7 Safe Havens All Investors Should Have Exposure to in 2022 ↗
Few stocks with deep value and growth prospects offer upside and safe havens for investors, with those picks the exception. 
Via InvestorPlace
News headline image
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands ↗
 
Via Benzinga
News headline image
Novartis' Cosentyx Shows To Ease Symptoms In Painful Skin Condition ↗
 
Via Benzinga
News headline image
Novartis Injects $300M In Early-Stage Biologics Research Tech ↗
 
Via Benzinga
News headline image
Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More.. ↗
Wall Street Journal 
Via Benzinga
News headline image
Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya ↗
 
Via Benzinga
News headline image
3 Stocks That Could Rocket on Biden’s Cancer Moonshot ↗
Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology. 
Via InvestorPlace
Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx
Continue reading "Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx" 
Via Get News
News headline image
Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting ↗
 
Via Benzinga
VideoKrtoon Offers State Of The Art 2D Animation Services
Via Prodigy
News headline image
Novartis To Spinoff Sandoz Business To Create #1 European Generics Company ↗
 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
News headline image
Top Financial Media Stories Thursday, September 15: US Railway Companies, Unions Reach Tentative Agreement, Tesla To Wind Down Stores In China's Flashy Malls, Netflix Could Face Legal Action Over South Korean Crime Drama And More.. ↗
US Railway Companies, Unions Reach Tentative Agreement Averting Catastrophic Strike 
Via Benzinga
News headline image
Swiss Competition Commission Investigates Novartis' Patent Use To Fend Off Competition ↗
The Swiss competition commission (COMCO) has initiated an investigation against Novartis AG (NYSE: NVS) over the alleged unlawful patent use to reduce competitive pressure.  
Via Benzinga
News headline image
Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims ↗
A federal judge dismissed a whistleblower lawsuit accusing Novartis AG (NYSE: NVS) of paying doctors kickbacks at "sham" speaker programs to boost prescriptions of its multiple sclerosis blockbuster... 
Via Benzinga
News headline image
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says ↗
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
What are Value Stocks? 
Via Benzinga
News headline image
Smart Manufacturing Market Share 2022 Size, Key Trends, Future Scope, Global Outlook, Investment Plans and Development Status by 2027
Smart Manufacturing Market 2022 | Major Key Players included in this Report are Pfizer , Novartis, Abbott Laboratories and Many More with SWOT Analysis by 2027 
Via SBWire
News headline image
No Early Relief for JW Therapeutics from Cancer Wonder Drug ↗
Key Takeaways: JW Therapeutics prices its new cancer therapy at around a million yuan, with the high production costs hard to bring down.  Large-scale market expansion is not going to be easy  The... 
Via Benzinga
News headline image
Appointment of Sachin Nanavati to PreveCeutical's Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"... 
Via Newsfile
News headline image
SiO2 Materials Science Names Yves Steffen as Chief Executive Officer
SiO2 Materials Science today announced the Board of Directors has appointed Yves Steffen as CEO effective Aug. 1, 2022. 
Via Newswire.com
News headline image
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗
Wall Street Journal 
Via Benzinga
News headline image
Novartis Appoints Merck Executive As Research Head ↗
 
Via Benzinga
News headline image
NYSE:NVS Investor Alert: Investigation over Potential Wrongdoing at Novartis AG ↗
San Diego, CA -- (SBWIRE) -- 08/30/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Novartis AG. 
Via SBWire
News headline image
Novartis' Scemblix Snags European Approval For Chronic Myeloid Leukemia ↗
 
Via Benzinga
News headline image
With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial ↗
Novartis AG (NYSE: NVS) suspended dosing in a Huntington's disease study because early signs of side effects were seen in some participants in the trial. 
Via Benzinga
News headline image
Benzinga Before The Bell: Twitter Whistleblower Peiter Zatko To Depose Before Senate Panel, GameStop To Boost Employee Compensation To Drive Growth, California Proposes Total Ban On New Gasoline Car Sales By 2035 And Other Top Financial Stories Thursday, ↗
Reuters Stuck By Chip Shortage, Stellantis Halts Production In Sochaux Plant 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.